Endowed with a €1.5 million grant from the European Institute of Innovation and Technology (EIT), the PRE-DETECT-HF project officially kicked off on 1 January, 2024. The grant will fund a ground-breaking clinical trial that aims to utilise AI-powered speech analysis for the early detection and treatment of heart failure.
This project will be carried out by a prestigious consortium of partners, led by Noah Labs, including Maastricht University Medical Center+, Clinic Barcelona, DKV Salud, ProductLife Group, Institute for Policy Evaluation, IDIBAPS and the German Foundation for the Chronically Ill.
Advancing heart failure monitoring through voice-based ADHF detection
The €1.5 million grant from EIT Health will fuel a two-year initiative aimed at advancing heart failure monitoring through voice-based detection of acutely decompensated heart failure (ADHF). The randomised controlled trial (RCT) conducted in Barcelona and Maastricht will involve around 200 patients. The study aims to evaluate the efficacy of voice analysis in identifying early warning signs and predicting ADHF exacerbations. This pioneering approach has the potential to revolutionise the management of ADHF by providing a non-invasive and cost-effective means of early detection, leading to improved patient outcomes and reduced hospitalisations.
As project lead, Noah Labs brings its expertise in developing AI-powered solutions for cardiovascular disease management. "We are thrilled to be at the forefront of this pioneering research," says Dr. Leonhard Riehle, Chief Medical Officer & Co-founder of Noah Labs. "Working alongside renowned medical institutions like Maastricht UMC+ and Clinic Barcelona, we are confident that this project will bring us closer to our shared mission: Empowering individuals with chronic conditions to live longer, healthier lives."
A Strong Consortium for Shared Success
The consortium brings together a diverse group of institutions, each playing a crucial role. Noah Labs provides the core technology and artificial intelligence expertise. Maastricht UMC+, a leading academic medical centre, provides clinical expertise and research infrastructure. Clinic Barcelona, a renowned cardiology centre, contributes its clinical experience and patient access. Additional partners DKV Salud (Spain), PLG (France), IPE-Institute for Policy Evaluation (Germany) and the German Foundation for the Chronically Ill (Germany) offer valuable insights from the insurance, regulatory, economic, and patient perspectives. Altogether, we will conduct a multi-centre, randomised and controlled trial to clinically validate the technology, improve the algorithm’s accuracy and accelerate the solution to market, starting in the Netherlands and Spain.
Positive Outlook for Cardiovascular Care
This collaborative effort reflects the growing potential of AI in transforming healthcare. By harnessing the power of voice analysis, the PRE-DETECT-HF project holds immense promise for revolutionising the management of heart failure, ultimately leading to better patient outcomes and improved quality of life.
About EIT Health
EIT Health is a network of best-in-class health innovators with approximately 120 partners and is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union. We collaborate across borders to deliver new solutions that can enable European citizens to live longer, healthier lives.
As Europeans tackle the challenge of increasing chronic diseases and multi-morbidity and seek to realise the opportunities that technology offers to move beyond conventional approaches to treatment, prevention and healthy lifestyles, we need thought leaders, innovators and efficient ways to bring innovative healthcare solutions to market.
Our commitment to driving healthcare advancement is evident in our proactive role in mentorship, funding, and research facilitation. Recognised as a pivotal player in healthcare innovation, EIT Health's record of accomplishment includes: catalysing over 2,500 start-ups and scale-ups, helping EIT Health-supported startups attract €1.9 billion in investment, propelling 113 healthcare solutions to the market, and training 49,000 students and professionals.
EIT Health addresses these needs. We connect all relevant healthcare players across European borders – making sure to include all sides of the “knowledge triangle”, so that innovation can happen at the intersection of research, education and business for the benefit of citizens.
EIT Health: Together for healthy lives in Europe. For more information visit: www.eithealth.eu.
About Noah Labs
Noah Labs is a Berlin-based digital health startup. Founded in 2021 by Oliver Weiss, Marcus Hott and Dr. Leonhard Riehle, the company aims to help people with cardiovascular diseases live longer, healthier lives. Marcus previously worked as an AI programmer at Harvard Medical School while Oliver, an economist, previously built the elderly care company Mecasa. Leonhard is a medical doctor who previously worked in the field of cardiovascular telemonitoring at Charité Berlin. Noah Labs has 15 employees and is ISO 13485 certified as a manufacturer of (software-based) medical devices. The company is currently conducting clinical trials with Charité in Berlin, the Mayo Clinic in the US, Maastricht UMC+ and Clinic Barcelona. Noah Labs is funded by EIT Health and the State of Berlin. It is also a member of the American Heart Association's Center for Health Technology & Innovation.
Further Information:
.webp)
